{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-323802","form_type":"8-K","ticker":"TMCI","cik":"0001630627","company_name":"TREACE MEDICAL CONCEPTS, INC.","filed_at":"2025-12-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.986384+00:00","generated_at":"2026-05-16T12:45:07.234444+00:00","sec_items":["1.01","1.02","2.03","3.03","7.01","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Treace Medical secures $175M debt facility, refinances MidCap loans; names lead independent director","bullets":["Entered $175M senior secured loan: $60M term funded, $65M additional term (revenue-dependent), $50M revolver (expandable from $30M).","Proceeds used to repay $50M term and $4M revolver from MidCap loans; paid $2.3M in prepayment/exit fees.","Term loan at 1-month SOFR (floor 3%) + 5.05%; revolver at 3-month SOFR (floor 3%) + 4%; interest-only for 48 months.","Post-refinancing liquidity ~$165M; dividends restricted under loan covenants.","Board appointed John K. Bakewell as lead independent director; former CFO of Exact Sciences."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-323802","json":"https://secwatch.observer/filing/0001193125-25-323802.json","markdown":"https://secwatch.observer/filing/0001193125-25-323802.md","text":"https://secwatch.observer/filing/0001193125-25-323802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1630627/000119312525323802/0001193125-25-323802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1630627/000119312525323802/tmci-20251216.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:45:07.234444+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"836204fc936f4d562d75d4a03e75f9f3bdd678a4","claim":"TREACE MEDICAL CONCEPTS, INC. incurred revolving credit of $30 million with Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL at 3-Month SOFR plus 4.00% maturing 60 month.","evidence_excerpt":"The Revolving Loan Agreement establishes a 60 month revolving loan facility providing $30 million in additional borrowing capacity to the Company.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312525323802/0001193125-25-323802-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"revolving credit"},{"label":"Principal","value":"$30 million"},{"label":"Counterparty","value":"Gemino Healthcare Finance, LLC d/b/a SLR Healthcare ABL"},{"label":"Rate","value":"3-Month SOFR plus 4.00%"},{"label":"Maturity","value":"60 month"},{"label":"Event","value":"incurrence"}]},{"claim_id":"fa84951b1170daef627d2d1f51f50782be2d8eba","claim":"TREACE MEDICAL CONCEPTS, INC. incurred term loan of up to $125 million with SLR Investment Corp. at 1-Month SOFR plus 5.05% maturing 60 month.","evidence_excerpt":"The Term Loan Agreement provides a 60 month term loan facility for up to $125 million in borrowing capacity to the Company over four tranches. At the loan closing, the Company drew $60 million under tranche one.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1630627/000119312525323802/0001193125-25-323802-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"term loan"},{"label":"Principal","value":"up to $125 million"},{"label":"Counterparty","value":"SLR Investment Corp."},{"label":"Rate","value":"1-Month SOFR plus 5.05%"},{"label":"Maturity","value":"60 month"},{"label":"Event","value":"incurrence"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}